Precision Syringe CEO Adrian Blake demonstrates his company’s patented syringe design to a guest during the May 28, 2026, Idea Pub: Morning Edition. The syringe was invented at UNMC.

OMAHA, Nebraska (May 28, 2026)—Adrian Blake, CEO of Precision Syringe, led Thursday’s Idea Pub: Morning Edition with an entertaining look at his journey in the Omaha startup world and a peek at what is still to come.

Precision Syringe was founded on an innovation created by former UNMC pediatric ophthalmologist Danny Suh, MD, who wanted more control when injecting children’s eyes with medication.

The Precision Syringe isn’t for flu shots, Blake said, but for incredibly delicate procedures where the smallest movements could be catastrophic, such as retinal injections.

Blake added that Precision Syringe expects to submit for FDA approval later this year, and soon-after will begin its Series A financing round.

Blake’s presentation was primed with five key lessons learned for other young startups and entrepreneurs.

He noted the importance of the “fit” between a founder and the desired market; understanding the complexity of the regulatory process as early as possible; leveraging existing networks; maintaining honesty about the product; and the “UNMC spinout cascade is real.”

Morning Edition is UNeMed’s and UNeTech Institute’s networking event for university innovators, entrepreneurs and startup community members. Catalyst Omaha co-sponsors the event and provides free tours of the spacious facility.

Morning Editions will continue to be a fixture in the Forge Event Hall, located on the north end of Catalyst Omaha in the EDGE District. Guided tours will also continue as an added feature.

The next Morning Edition is planned for Thursday, June 25, 2026, at 9-11 a.m.